Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Anacor presents results from phase II psoriasis trial with AN-2728

Feb. 20, 2009

Capstone commences dosing in phase II AZX-100 trial in dermal scarring

Feb. 11, 2009

FDA approves Galderma's Vectical for mild to moderate plaque psoriasis

Feb. 5, 2009

Foamix and VIB sign codevelopment agreement to investigate Caspase-14 for psoriasis

Feb. 4, 2009

Revotar Biopharmaceuticals starts phase II bimosiamose 5% cream trial

Feb. 2, 2009

Isotechnika provides update on its lead product voclosporin

Jan. 30, 2009

Patient recruitment completed in Biofrontera's phase III BF-200 ALA study

Jan. 30, 2009

FDA allows Clinuvel to begin U.S. clinical trials of afamelanotide

Jan. 29, 2009

Kringle receives approval for ChronSeal CTA and signs option agreement with Maruho

Jan. 29, 2009

Tripep initiates phase II study in Norway and Sweden of ChronSeal for chronic leg wounds

Jan. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...